The forum, positioned at the beginning of JPM week, focuses on the latest developments across key areas of Neuroscience which are currently drawing widespread investor interest. The program features 8+ hours of keynotes and panel discussions addressing the important advances in therapeutic, neurotech and diagnostics fields.
Lumanity will be chairing a panel:
Meeting the Promise of Psychedelics Panel: Expected Trends for 2026
Chaired by: Ginger Johnson, President, BioConsulting, Lumanity
Connect with our staff or schedule a time to meet during the meeting by reaching out to contact@lumanity.com.